Sign In
Buy AXGN
$42.21
+0.86 (+2.08%)
At Close: Jul 31, 2026
Are Medical Stocks Lagging Catalyst Pharmaceuticals (CPRX) This Year?
01:40pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Here is how Catalyst Pharmaceutical (CPRX) and AxoGen (AXGN) have performed compared to their sector so far this year.
AxoGen (AXGN) Soars 8.6%: Is Further Upside Left in the Stock?
09:32am, Thursday, 29'th Sep 2022 Zacks Investment Research
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
AxoGen (AXGN) Soars 8.6%: Is Further Upside Left in the Stock?
06:47am, Thursday, 29'th Sep 2022
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
07:23am, Monday, 12'th Sep 2022 Benzinga
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in
Wall Street Analysts Think AxoGen (AXGN) Could Surge 89%: Read This Before Placing a Bet
01:55pm, Monday, 08'th Aug 2022 Zacks Investment Research
The consensus price target hints at an 89.4% upside potential for AxoGen (AXGN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
01:40pm, Monday, 08'th Aug 2022 Zacks Investment Research
Here is how Acadia Healthcare (ACHC) and AxoGen (AXGN) have performed compared to their sector so far this year.
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q2 2022 Results - Earnings Call Transcript
10:13am, Saturday, 06'th Aug 2022
AxoGen, Inc. (NASDAQ:AXGN ) Q2 2022 Results Conference Call August 3, 2022 4:30 PM ET Company Participants Ed Joyce - Director, IR Karen Zaderej - Chairman, President & CEO Peter Mariani - EVP & CFO C
AxoGen (AXGN) Reports Q2 Loss, Tops Revenue Estimates
09:25pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
AxoGen (AXGN) delivered earnings and revenue surprises of 60% and 5.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AxoGen (AXGN) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Wednesday, 03'rd Aug 2022
AxoGen (AXGN) delivered earnings and revenue surprises of 60% and 5.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AxoGen: Investors Are Positioned Long Leading Into Q2 FY22 Earnings
03:21pm, Tuesday, 02'nd Aug 2022
AxoGen is set to report Q2 FY22 earnings on Wednesday, following a period of flat performance on the chart. The company released top-line forecasts in its earnings pre-release from July, implying a pe
Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference
11:00am, Friday, 29'th Jul 2022 GlobeNewswire Inc.
ALACHUA. Fla. and TAMPA, Fla, July 29, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference
07:00am, Friday, 29'th Jul 2022
ALACHUA. Fla. and TAMPA, Fla, July 29, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, to
Read JMP Securities' Take On Axogen's Interim Update
07:26pm, Wednesday, 20'th Jul 2022 Benzinga
Axogen Inc (NASDAQ: AXGN) reported interim Q2 sales expectations of $34.4 million (+2% y/y; +8% excluding Avive sales in 2Q21) ahead of the consensus of ~$33.5 million.
JMP reiterated the Market O
Axogen, Inc. Appoints William Burke to Board of Directors
11:00am, Monday, 11'th Jul 2022 GlobeNewswire Inc.
Burke brings 25+ years of global financial leadership experience to the Axogen, Inc. Board of Directors Burke brings 25+ years of global financial leadership experience to the Axogen, Inc. Board of Di
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
02:07pm, Monday, 09'th May 2022 Benzinga
Upgrades
For Axogen Inc (NASDAQ:AXGN), Canaccord Genuity upgraded the previous rating of Hold to Buy. Axogen earned $0.20 in the first quarter, compared to $0.08 in the year-ago quarter. The stock has
